12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension

Stopped early · Phase 3

Conditions studied: Alzheimer's Disease

In brief

This 12-month open-label study will provide further information regarding the long-term safety and tolerability of intepirdine (RVT-101) for subjects with Alzheimer's disease who have completed the double-blind, placebo-controlled, lead-in study RVT-101-3001 (double-blind study).

Key facts

Study ID

NCT02586909

Run by

Axovant Sciences Ltd.

People needed

1099

Starts

2016-04-26

Expected to finish

2018-03-12

Last updated by the study team

2020-04-17

Who can join

Age: 50 and older, up to 86. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Completed last on-treatment visit of the lead-in study RVT-101-3001

You may not qualify if…

• Any clinically relevant concomitant disease, which, in the opinion of the investigator, makes the subject unsuitable for inclusion in the study.

Where it is running

• US220 — Tucson, Arizona, United States
• US096 — Rancho Mirage, California, United States
• US195 — Santa Ana, California, United States
• US016 — Simi Valley, California, United States
• US106 — Temecula, California, United States
• US179 — Hamden, Connecticut, United States
• US171 — Norwich, Connecticut, United States
• US088 — Atlantis, Florida, United States
• US007 — Brooksville, Florida, United States
• US002 — Hallandale, Florida, United States
• US140 — Hialeah, Florida, United States
• US216 — Miami, Florida, United States
• US110 — Miami, Florida, United States
• US172 — North Palm Beach, Florida, United States
• US003 — Orlando, Florida, United States
• US256 — Pensacola, Florida, United States
• US037 — Tampa, Florida, United States
• US042 — Tampa, Florida, United States
• US004 — The Villages, Florida, United States
• US048 — Atlanta, Georgia, United States
• US046 — Atlanta, Georgia, United States
• US217 — Columbus, Georgia, United States
• US111 — Baton Rouge, Louisiana, United States
• US095 — Shreveport, Louisiana, United States
• US112 — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.